Status:
COMPLETED
Non-Eosinophilic Neutrophilic Asthma
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Collaborating Sponsors:
Spanish Clinical Research Network - SCReN
Conditions:
Neutrophilic Asthma
Eligibility:
All Genders
18-80 years
Brief Summary
Define and characterize the neutrophilic phenotype of severe asthma.
Detailed Description
Neutrophilic asthma (NA) is the asthma phenotype less known, causes a severe disease and does not have a specific treatment. Research on the neutrophilia mechanisms, new neutrophil (NEU) types and bro...
Eligibility Criteria
Inclusion
- 18 - 80 years old
- Confirmed diagnosis of asthma (according to spanish guideline GEMA)
- Severe persistent asthma (step 5-6 GEMA)
- Eosinophils\<300/mm3 in peripheral blood
Exclusion
- Respiratory infection during the previous month
- Significant lung pathology not attributable to asthma (bronchiectasis with Reiff score\>3)
Key Trial Info
Start Date :
February 21 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2023
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03479138
Start Date
February 21 2018
End Date
July 30 2023
Last Update
January 11 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de la Santa Creu i Sant Pau. Carrer Mas Casanovas 90.
Barcelona, Spain, 08041
2
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain, 08041